AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

COGSTATE LTD Board/Management Information 2009

Nov 8, 2009

64644_rns_2009-11-08_999870ea-e7eb-4d69-b0c5-df98806748f5.pdf

Board/Management Information

Open in viewer

Opens in your device viewer

==> picture [235 x 49] intentionally omitted <==

ASX Announcement

Monday 9 November 2009

CogState Appoints Company Secretary

CogState Ltd (ASX: CGS) is pleased to announce the appointment of Lauren Delaney as Company Secretary, replacing Tony Panther.

Lauren joined CogState in September 2006. She previously held the role of Company Secretary from April 2007 until August 2008, when she commenced fourteen months leave.

In addition to her appointment as Company Secretary, Lauren will act as Finance Manager at CogState Ltd.

About CogState

CogState Ltd (ASX: CGS) specialises in the development and commercialisation of rapid, computerised tests of cognition (brain function). The tests are sold to pharmaceutical, biotechnology, nutraceutical and functional food companies to quantify the effect of drugs or other interventions on human subjects participating in clinical trials.

Since sales into the clinical trials market began in 2004, CogState has secured agreements with organisations including Pfizer, AstraZeneca, GlaxoSmithKline, Merck, Abbott Laboratories, Centres for Disease Control (USA), ALZA Corporation (a member of the Johnson and Johnson group), Lundbeck and Organon USA. CogState is currently expanding its existing activities in the US and European clinical trial markets.